These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27763997)

  • 1. Closing the Gap in Antiretroviral Initiation and Viral Suppression: Time Trends and Racial Disparities.
    Haines CF; Fleishman JA; Yehia BR; Lau B; Berry SA; Agwu AL; Moore RD; Gebo KA
    J Acquir Immune Defic Syndr; 2016 Nov; 73(3):340-347. PubMed ID: 27763997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the disparity: predictors of virologic failure in women using highly active antiretroviral therapy vary by race and/or ethnicity.
    McFall AM; Dowdy DW; Zelaya CE; Murphy K; Wilson TE; Young MA; Gandhi M; Cohen MH; Golub ET; Althoff KN;
    J Acquir Immune Defic Syndr; 2013 Nov; 64(3):289-98. PubMed ID: 23797695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HIV Care Cascade Measured Over Time and by Age, Sex, and Race in a Large National Integrated Care System.
    Horberg MA; Hurley LB; Klein DB; Towner WJ; Kadlecik P; Antoniskis D; Mogyoros M; Brachman PS; Remmers CL; Gambatese RC; Blank J; Ellis CG; Silverberg MJ
    AIDS Patient Care STDS; 2015 Nov; 29(11):582-90. PubMed ID: 26505968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding Cross-Sectional Racial, Ethnic, and Gender Disparities in Antiretroviral Use and Viral Suppression Among HIV Patients in the United States.
    Beer L; Mattson CL; Bradley H; Skarbinski J;
    Medicine (Baltimore); 2016 Mar; 95(13):e3171. PubMed ID: 27043679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95%.
    Shuter J; Sarlo JA; Kanmaz TJ; Rode RA; Zingman BS
    J Acquir Immune Defic Syndr; 2007 May; 45(1):4-8. PubMed ID: 17460469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparities in Initiation of Combination Antiretroviral Treatment and in Virologic Suppression Among Patients in the HIV Outpatient Study, 2000-2013.
    Novak RM; Hart RL; Chmiel JS; Brooks JT; Buchacz K;
    J Acquir Immune Defic Syndr; 2015 Sep; 70(1):23-32. PubMed ID: 25886926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Care and viral suppression during the last year of life among persons with HIV who died in 2012, 18 US jurisdictions.
    Hall HI; Espinoza L; Harris S; Shi J
    AIDS Care; 2016; 28(5):574-8. PubMed ID: 26643945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using the HIV surveillance system to monitor the National HIV/AIDS Strategy.
    Mahle Gray K; Tang T; Shouse L; Li J; Mermin J; Hall HI
    Am J Public Health; 2013 Jan; 103(1):141-7. PubMed ID: 23153150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retention in HIV Care and Viral Suppression: Individual- and Neighborhood-Level Predictors of Racial/Ethnic Differences, Florida, 2015.
    Sheehan DM; Fennie KP; Mauck DE; Maddox LM; Lieb S; Trepka MJ
    AIDS Patient Care STDS; 2017 Apr; 31(4):167-175. PubMed ID: 28414260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disparity in Retention in Care and Viral Suppression for Black Caribbean-Born Immigrants Living with HIV in Florida.
    Cyrus E; Dawson C; Fennie KP; Sheehan DM; Mauck DE; Sanchez M; Maddox LM; Trepka MJ
    Int J Environ Res Public Health; 2017 Mar; 14(3):. PubMed ID: 28282947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex, Race, and HIV Risk Disparities in Discontinuity of HIV Care After Antiretroviral Therapy Initiation in the United States and Canada.
    Rebeiro PF; Abraham AG; Horberg MA; Althoff KN; Yehia BR; Buchacz K; Lau BM; Sterling TR; Gange SJ
    AIDS Patient Care STDS; 2017 Mar; 31(3):129-144. PubMed ID: 28282246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disparities in Viral Suppression and Medication Adherence among Women in the USA, 2011-2016.
    Geter A; Sutton MY; Armon C; Buchacz K;
    AIDS Behav; 2019 Nov; 23(11):3015-3023. PubMed ID: 30968277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial differences in response to antiretroviral therapy for HIV infection: an AIDS clinical trials group (ACTG) study analysis.
    Ribaudo HJ; Smith KY; Robbins GK; Flexner C; Haubrich R; Chen Y; Fischl MA; Schackman BR; Riddler SA; Gulick RM
    Clin Infect Dis; 2013 Dec; 57(11):1607-17. PubMed ID: 24046302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial and socioeconomic disparities in viral suppression among persons living with HIV in New York City.
    Xia Q; Robbins RS; Lazar R; Torian LV; Braunstein SL
    Ann Epidemiol; 2017 May; 27(5):335-341. PubMed ID: 28511865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009.
    Hanna DB; Buchacz K; Gebo KA; Hessol NA; Horberg MA; Jacobson LP; Kirk GD; Kitahata MM; Korthuis PT; Moore RD; Napravnik S; Patel P; Silverberg MJ; Sterling TR; Willig JH; Lau B; Althoff KN; Crane HM; Collier AC; Samji H; Thorne JE; Gill MJ; Klein MB; Martin JN; Rodriguez B; Rourke SB; Gange SJ;
    Clin Infect Dis; 2013 Apr; 56(8):1174-82. PubMed ID: 23315317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic function and virologic suppression among children with perinatally acquired HIV Infection on highly active antiretroviral therapy.
    Rutstein RM; Gebo KA; Flynn PM; Fleishman JA; Sharp VL; Siberry GK; Spector SA
    Med Care; 2005 Sep; 43(9 Suppl):III15-22. PubMed ID: 16116305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Black-White and Country of Birth Disparities in Retention in HIV Care and Viral Suppression among Latinos with HIV in Florida, 2015.
    Sheehan DM; Mauck DE; Fennie KP; Cyrus EA; Maddox LM; Lieb S; Trepka MJ
    Int J Environ Res Public Health; 2017 Jan; 14(2):. PubMed ID: 28134795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Race and Ethnicity With Initial Prescription of Antiretroviral Therapy Among People With HIV in the US.
    Zalla LC; Cole SR; Eron JJ; Adimora AA; Vines AI; Althoff KN; Silverberg MJ; Horberg MA; Marconi VC; Coburn SB; Lang R; Williams EC; Gill MJ; Gebo KA; Klein M; Sterling TR; Rebeiro PF; Mayor AM; Moore RD; Edwards JK
    JAMA; 2023 Jan; 329(1):52-62. PubMed ID: 36594946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparities in outcomes for African American and Latino subjects in the Flexible Initial Retrovirus Suppressive Therapies (FIRST) trial.
    Giordano TP; Bartsch G; Zhang Y; Tedaldi E; Absalon J; Mannheimer S; Thomas A; MacArthur RD
    AIDS Patient Care STDS; 2010 May; 24(5):287-95. PubMed ID: 20438378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends of racial and ethnic disparities in virologic suppression among women in the HIV Outpatient Study, USA, 2010-2015.
    Geter A; Sutton MY; Armon C; Durham MD; Palella FJ; Tedaldi E; Hart R; Buchacz K;
    PLoS One; 2018; 13(1):e0189973. PubMed ID: 29293632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.